Securities code: 688166 securities abbreviation: Brightgene Bio-Medical Technology Co.Ltd(688166) Announcement No.: 2022-005 Borui biomedical (Suzhou) Co., Ltd
Suggestive announcement on the change of shareholders’ equity holding more than 5%
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. Important content tips:
This equity change is to fulfill the share reduction plan previously disclosed, and does not touch the tender offer.
After this equity change, Sequoia Zhisheng equity investment partnership (limited partnership) (hereinafter referred to as “Sequoia Zhisheng” or “information disclosure obligor”) in Ningbo Meishan free trade port area held 20499801 shares of Borui biomedical (Suzhou) Co., Ltd. (hereinafter referred to as “the company”), and the proportion of shares held by the company decreased from 7.00607% to 4.99995%.
This equity change will not lead to changes in the controlling shareholder and actual controller of the company.
The company received the short form equity change report issued by Sequoia Zhisheng on January 18, 2022, and now announces the relevant equity changes as follows:
1、 Changes in equity this time
(I) basic information of information disclosure obligor name of information disclosure obligor Sequoia Zhisheng equity investment partnership (limited partnership) in Ningbo Meishan free trade port area
Domicile / registered address: g0172, zone B, Room 401, building 1, No. 88, Qixing Road, Meishan, Beilun District, Ningbo City, Zhejiang Province
Registered capital: RMB 7501 million
Mailing address: 3606, building 3, Huamao Center office building, No. 77, Jianguo Road, Chaoyang District, Beijing
Executive partner: Jiaxing Sequoia kunsheng investment management partnership (limited partnership)
Unified social credit code 91330206ma2935ap7d
Type of enterprise: limited partnership
Equity investment and related consulting services (without the approval of financial and other regulatory authorities, it is not allowed to engage in financial businesses such as deposit taking, financing guarantee, customer financing and capital collection (financing) from the public) (for projects subject to approval according to law, business activities can be carried out only with the approval of relevant departments)
Major shareholder or sponsor: Jiaxing Sequoia kunsheng investment management partnership (limited partnership)
Sequoia Mingsheng equity investment partnership (limited partnership) in Ningbo Meishan free trade port area
Sequoia Jiasheng equity investment partnership (limited partnership) in Ningbo Meishan free trade port area
Operation period: August 9, 2017 to August 8, 2029
Date of establishment: August 9, 2017
(II) basic information of this equity change
Change method change date share type reduction quantity reduction proportion (%) (shares)
Block trading November 2, 2021 – RMB common stock 7111100 1.73441
December 22
Centralized bidding RMB 1113974 ordinary shares 0.27170 on December 24, 2021
Transaction – January 17, 2022
Total – 8225074 2.00612
Note: 1. The tail difference between the total and the sum of the itemized values is caused by rounding.
2. All the shares involved in this equity change enjoy voting rights, and there are no rights restrictions or restricted transfers such as voting rights entrustment or restriction.
3. This equity change complies with the disclosed reduction plan of Sequoia Zhisheng, and there is no violation of laws and regulations such as the securities law, the measures for the administration of the acquisition of listed companies and the business rules of Shanghai Stock Exchange.
2、 Shareholding before and after this equity change
Shares held by shareholders before this change and shares held after this change
Name share nature share number (share) in total share capital share number (share) in total share capital (%) case (%)
Sequoia holds shares in total 28724875 7.00607 20499801 4.99995
Zhisheng shares with unlimited sales conditions 21912569 5.34453 13687495 3.33841
Shares with limited sales conditions 6812306 1.66154 6812306 1.66154
Note: 1. The tail difference between the total and the sum of the itemized values is caused by rounding.
2. On December 10, 2021, 13624613 initial restricted shares held by Sequoia Zhisheng were listed and circulated.
3、 Description of other changes in equity
(I) this equity change will not lead to the change of the controlling shareholder and actual controller of the company, and will not have an impact on the corporate governance structure, equity structure and sustainable operation.
(II) this equity change is a reduction, which does not involve tender offer and capital source.
(III) after this equity change, Sequoia Zhisheng will no longer be the shareholder holding more than 5% of the company’s shares. According to the provisions of laws, regulations and normative documents such as the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies and the standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity, this change in equity involves that the information disclosure obligor needs to disclose a simplified report on changes in equity, Please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Short form equity change report disclosed.
It is hereby announced.
Board of directors of Borui biomedical (Suzhou) Co., Ltd. January 19, 2022
